Spot sign on 90 second delayed CTA improves sensitivity for hematoma expansion and mortality: a prospective study

BACKGROUND AND PURPOSE: The CTA spot sign is a validated biomarker for poor outcome and hematoma expansion in intracerebral hemorrhage (ICH). The spot sign has proven to be a dynamic entity, with multimodal imaging proving to be of additional value. We investigated whether the addition of a 90 secon...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ciura, Viesha A., Brouwers, H. Bart, Pizzolato, Raffaella, Ortiz, Claudia J., Rosand, Jonathan, Goldstein, Joshua, Greenberg, Steven M., Pomerantz, Stuart R, Gonzalez, R. Gilberto, Romero, Javier M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4213346/
https://ncbi.nlm.nih.gov/pubmed/25300974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.114.005570
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi